Cordelia Cruise owner files DRHP, Biocon launches ₹4,500-crore QIP, more

In a busy week for the capital markets, Cordelia Cruise, a leading cruise line operator in India, has filed its Draft Red Herring Prospectus (DRHP) with SEBI for its Initial Public Offering (IPO). The company is looking to raise funds to expand its fleet and operations. Simultaneously, the biotechnology major, Biocon, has launched a Qualified Institutional Placement (QIP) to raise up to Rs 4,500 crore. A QIP is a mechanism for a listed company to raise capital from institutional investors without having to go through a full public issue process. These two major fundraising activities highlight the renewed confidence in the Indian capital markets. They represent companies from different sectors—travel and pharmaceuticals—tapping the market to fund their growth ambitions, indicating a positive outlook for both the primary and secondary markets.